Natco Pharma shares extend fall; down 5% on USFDA observations
Continuing to fall for the second consecutive day, shares of Natco Pharma fell by nearly 5 percent today, after the company received 483 observations from the USFDA after inspection of its two facilities.
Mar 29, 2016, 14:22 PM IST